DRG Epidemiology's coverage of chronic low back pain (CLBP) comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of CLBP for…
DRG Epidemiology's coverage of chronic low back pain (CLBP) comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of CLBP for…
DRG Epidemiology's coverage of chronic low back pain (CLBP) comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of CLBP for…
KEY BENEFITS AND USES Pinpoint current drug positioning and uptake in one snapshot to facilitate forecasting. Drill down into physicians’ treatment sequences and understand who to position…
Amyotrophic lateral sclerosis (ALS) is a progressively debilitating disorder of the central nervous system characterized by motor neuron degeneration. ALS causes progressive weakness and atrophy of…
Tumor necrosis factor-alpha (TNF-α) inhibitors (e.g., AbbVie’s Humira, Amgen’s Enbrel) and Janssen’s interleukin (IL)-12/23 inhibitor Stelara have been leading the U.S. psoriasis biologics…
Epidemiology Data Slicer – Gastric Cancer
Epidemiology Data Slicer – Rheumatoid Arthritis
Epidemiology Data Slicer – Dermatitis
Epidemiology Data Slicer – Ulcerative Colitis
Since 2018, four novel calcitonin gene-related peptide (CGRP)-targeting monoclonal antibodies (MAbs)—Novartis / Amgen’s Aimovig, Eli Lilly’s Emgality, Teva’s Ajovy, and Lundbeck’s Vyepti…
Epidemiology Data Slicer – Chronic Heart Failure
DRG Epidemiology’s coverage of actinic keratosis (AK) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany…
Epidemiology Data Slicer – Multiple Sclerosis
DRG Epidemiology's coverage of atrial fibrillation comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of atrial fibrillation…